PROPOFOL is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Propofol.
| Product ID | 0409-4699_6739d85f-7f91-4b20-a360-618fa638cbf8 |
| NDC | 0409-4699 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROPOFOL |
| Generic Name | Propofol |
| Dosage Form | Injection, Emulsion |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-04-03 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077908 |
| Labeler Name | Hospira, Inc. |
| Substance Name | PROPOFOL |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2006-04-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-01-06 |
| Marketing End Date | 2014-08-26 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2006-04-03 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-06-20 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-06-20 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2006-04-03 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-01-06 |
| Marketing End Date | 2014-08-26 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-01-06 |
| Marketing End Date | 2014-08-26 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-06-20 |
| Marketing Category | ANDA |
| Application Number | ANDA077908 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2006-04-04 |
| Ingredient | Strength |
|---|---|
| PROPOFOL | 10 mg/mL |
| SPL SET ID: | 28d7ba00-f824-4e55-139a-03f509c099db |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0209 | Propofol | Propofol |
| 0069-0234 | Propofol | Propofol |
| 0069-0248 | Propofol | Propofol |
| 0404-9943 | PROPOFOL | propofol |
| 0409-4699 | PROPOFOL | PROPOFOL |
| 0409-6010 | PROPOFOL | PROPOFOL |
| 0591-2136 | Propofol | Propofol |
| 0641-6194 | Propofol | Propofol |
| 0641-6195 | Propofol | Propofol |
| 0641-6196 | Propofol | Propofol |
| 16714-528 | propofol | propofol |
| 16714-690 | propofol | propofol |
| 16714-977 | propofol | propofol |
| 23155-345 | propofol | propofol |
| 25021-608 | propofol | propofol |
| 50090-4569 | Propofol | Propofol |
| 51662-1293 | PROPOFOL | PROPOFOL |
| 51662-1470 | PROPOFOL | PROPOFOL |
| 51662-1471 | PROPOFOL | PROPOFOL |
| 52584-054 | Propofol | Propofol |
| 52584-098 | PROPOFOL | propofol |
| 52584-699 | Propofol | Propofol |
| 18124-027 | Fresenius Propoven 2% | PROPOFOL |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PROPOFOL 90235915 not registered Live/Pending |
Twilight Co. 2020-10-05 |
![]() PROPOFOL 87725806 5534295 Live/Registered |
Liu Xiaojiao 2017-12-19 |